Stockreport

Standard BioTools: Outlook Still Murky [Seeking Alpha]

Standard BioTools Inc.  (LAB) 
PDF LAB will receive $350M upfront and up to $75M in earnouts from Illumina for SomaScan, leaving $550M in cash post-transaction. Management projects Adj. EBITDA breakeve [Read more]